Polpharma Finished Dosage Formulation Dossier - Under Development - Pharmaceutical Technology

Pharmaceutical Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X

Advertise with us

DOWNLOAD WHITEPAPER

Polpharma Finished Dosage Formulation Dossier – Under Development

This white paper outlines Polpharma B2B's finished dosage formulations (FDF) that are currently under development. Products listed include Esomeprazole powder for the treatment of peptic ulcers and gastro-oesophageal reflux disease, Orlistat anti-obesity capsules, Sitagliptin film-coated tablets for reducing blood glucose, and the Aciclovir antiviral tablets for systemic use. Download this brochure to find out more.

Download to find out more.

DOWNLOAD
Email*

Submit

DOWNLOAD WHITEPAPER

Polpharma Finished Dosage Formulation Dossier – Under Development

This white paper outlines Polpharma B2B's finished dosage formulations (FDF) that are currently under development. Products listed include Esomeprazole powder for the treatment of peptic ulcers and gastro-oesophageal reflux disease, Orlistat anti-obesity capsules, Sitagliptin film-coated tablets for reducing blood glucose, and the Aciclovir antiviral tablets for systemic use. Download this brochure to find out more.

Download to find out more.

DOWNLOAD

We just need a few more details

Name* Company* Job Title*

If you would like to hear from carefully selected third party companies, check this box

Verdict Media Limited uses the information in this form to provide you with occasional updates on new products and reports in accordance with your preferences. You are in control of the communications you receive from us and you can update your preferences anytime to make sure you are receiving information that matters to you. Please check our Privacy Policy to see how we protect and manage your submitted data